CORVANTA
LIVE

Serial Number

50081067

Owner

Corvanta, LLC

Attorney

Adam Neville

Filing Date

Aug 31, 2026

Add to watchlist:

No watchlists yet
View on USPTO

CORVANTA Trademark

Serial Number: 50081067

CORVANTA is a trademark filed by Corvanta, LLC on August 31, 2026. The trademark is classified under Class 5 (Pharmaceuticals), Class 44 (Medical Services), Class 35 (Advertising & Business). The application is currently pending registration.

Owner Contact Info

Corvanta, LLC

450 N 1500 W
Orem, UT 84057

Entity Type: 16

Trademark Details

Filing Date

August 31, 2026

Registration Date

Not Registered

Goods & Services

Retail pharmacy services; online retail pharmacy services; retail pharmacy services featuring prescription medications and compounded pharmaceutical preparations; online retail store services featuring prescription medications and compounded pharmaceutical preparations.

Medical services; telemedicine services; medical consultation services; health care services; providing medical information; providing health information; medical services in the fields of weight management, metabolic health, hormone health, and wellness; medical evaluation and treatment services in the fields of weight management, metabolic disorders, and hormone-related conditions; providing medical advice and information concerning prescription medications, pharmaceutical preparations, compounded medications, peptide therapies, and weight management treatments; medical counseling relating to pharmaceutical and therapeutic treatment options; pharmacy advice; preparation and dispensing of medications.

Pharmaceutical preparations; pharmaceutical preparations for the treatment of metabolic, endocrine, hormonal, nutritional, gastrointestinal, inflammatory, and weight-related diseases and disorders; compounded pharmaceutical preparations for medical purposes for the treatment of metabolic, endocrine, hormonal, nutritional, gastrointestinal, inflammatory, and weight-related diseases and disorders; peptide-based pharmaceutical preparations for medical purposes; peptides for medical purposes; pharmaceutical preparations containing peptides; pharmaceutical preparations containing glucagon-like peptide-1 (GLP-1) receptor agonists.

Filing History

APPLICATION FILING RECEIPT MAILED
Aug 31, 2026 MAFR
NEW APPLICATION ENTERED
Aug 31, 2026 NWAP